+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Orthobiologics Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5319120
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical
  • Kuros Biosciences Ltd.
  • Orthofix Inc.
  • Sanofi
Orthobiologics Devices And Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global orthobiologics devices and equipment market as it emerges from the COVID-19 shut down.







Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the orthobiologics devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Orthobiologics Devices And Equipment Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) By Product Type: Demineralized Bone Matrix; Synthetic Bone Substitutes; Stem Cell Therapy; Plasma-Rich Protein; Viscosupplementation; Bone Morphogenetic Protein; Synthetic Orthobiologics
2) By Application: Osteoarthritis and Degenerative Arthritis; Soft-Tissue Injuries; Fracture Recovery; Maxillofacial and Dental Applications; Spinal Fusion; Trauma Repair; Reconstructive Surgery
3) By End Use: Hospitals; Orthopedic Clinics; Others

Companies Mentioned: Medtronic; Arthrex Inc.; DePuy Synthes (A Subsidiary of Johnson & Johnson); Stryker Corporation; Zimmer Biomet

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Orthobiologics Devices and Equipment Market

What is the estimated value of the Global Orthobiologics Devices and Equipment Market?

The Global Orthobiologics Devices and Equipment Market was estimated to be valued at $6.0 billion in 2021.

What is the growth rate of the Global Orthobiologics Devices and Equipment Market?

The growth rate of the Global Orthobiologics Devices and Equipment Market is 7.0%, with an estimated value of $7.9 billion by 2025.

What is the forecasted size of the Global Orthobiologics Devices and Equipment Market?

The Global Orthobiologics Devices and Equipment Market is estimated to be worth $7.9 billion by 2025.

Who are the key companies in the Global Orthobiologics Devices and Equipment Market?

Key companies in the Global Orthobiologics Devices and Equipment Market include Medtronic, Arthrex Inc., DePuy Synthes (A Subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet, Bioventus LLC, Baxter International Inc., Integra Lifesciences Holding Corporation and Sanofi.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical
  • Kuros Biosciences Ltd.
  • Orthofix Inc.
  • Sanofi

1. Executive Summary2. Orthobiologics Devices And Equipment Market Characteristics3. Orthobiologics Devices And Equipment Market Trends And Strategies4. Impact Of COVID-19 on Orthobiologics Devices And Equipment
5. Orthobiologics Devices And Equipment Market Size And Growth
5.1. Global Orthobiologics Devices And Equipment Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Orthobiologics Devices And Equipment Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Orthobiologics Devices And Equipment Market Segmentation
6.1. Global Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Demineralized Bone Matrix
  • Synthetic Bone Substitutes
  • Stem Cell Therapy
  • Plasma-Rich Protein
  • Viscosupplementation
  • Bone Morphogenetic Protein
  • Synthetic Orthobiologics
6.2. Global Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Osteoarthritis and Degenerative Arthritis
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications
  • Spinal Fusion
  • Trauma Repair
  • Reconstructive Surgery
6.3. Global Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Others

7. Orthobiologics Devices And Equipment Market Regional And Country Analysis
7.1. Global Orthobiologics Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Orthobiologics Devices And Equipment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Orthobiologics Devices And Equipment Market
8.1. Asia-Pacific Orthobiologics Devices And Equipment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.4. Asia-Pacific Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Orthobiologics Devices And Equipment Market
9.1. China Orthobiologics Devices And Equipment Market Overview
9.2. China Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.4. China Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Orthobiologics Devices And Equipment Market
10.1. India Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.3. India Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Orthobiologics Devices And Equipment Market
11.1. Japan Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.3. Japan Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Orthobiologics Devices And Equipment Market
12.1. Australia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.3. Australia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Orthobiologics Devices And Equipment Market
13.1. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.3. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Orthobiologics Devices And Equipment Market
14.1. South Korea Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.3. South Korea Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Orthobiologics Devices And Equipment Market
15.1. Western Europe Orthobiologics Devices And Equipment Market Overview
15.2. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.4. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Orthobiologics Devices And Equipment Market
16.1. UK Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.3. UK Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Orthobiologics Devices And Equipment Market
17.1. Germany Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.3. Germany Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Orthobiologics Devices And Equipment Market
18.5. France Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.6. France Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.7. France Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Orthobiologics Devices And Equipment Market
19.1. Eastern Europe Orthobiologics Devices And Equipment Market Overview
19.2. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.4. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Orthobiologics Devices And Equipment Market
20.1. Russia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.3. Russia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Orthobiologics Devices And Equipment Market
21.1. North America Orthobiologics Devices And Equipment Market Overview
21.2. North America Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.4. North America Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Orthobiologics Devices And Equipment Market
22.1. USA Orthobiologics Devices And Equipment Market Overview
22.2. USA Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.4. USA Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Orthobiologics Devices And Equipment Market
23.1. South America Orthobiologics Devices And Equipment Market Overview
23.2. South America Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.4. South America Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Orthobiologics Devices And Equipment Market
24.1. Brazil Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.3. Brazil Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Orthobiologics Devices And Equipment Market
25.1. Middle East Orthobiologics Devices And Equipment Market Overview
25.2. Middle East Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.4. Middle East Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Orthobiologics Devices And Equipment Market
26.1. Africa Orthobiologics Devices And Equipment Market Overview
26.2. Africa Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.4. Africa Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Orthobiologics Devices And Equipment Market Competitive Landscape And Company Profiles
27.1. Orthobiologics Devices And Equipment Market Competitive Landscape
27.2. Orthobiologics Devices And Equipment Market Company Profiles
27.2.1. Medtronic
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Arthrex Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. DePuy Synthes (A Subsidiary of Johnson & Johnson)
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Stryker Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Zimmer Biomet
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Orthobiologics Devices And Equipment Market29. Orthobiologics Devices And Equipment Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical
  • Kuros Biosciences Ltd.
  • Orthofix Inc.
  • Sanofi
Major players in the orthobiologics devices and equipment market are Medtronic, Arthrex Inc., DePuy Synthes (A Subsidiary of Johnson & Johnson), Stryker Corporation, and Zimmer Biomet.

The global orthobiologics devices and equipment market is expected to grow from $5.23 billion in 2020 to $5.98 billion in 2021 at a compound annual growth rate (CAGR) of 14.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.85 billion in 2025 at a CAGR of 7%.

The orthobiologics devices and equipment market consists of sales of orthobiologics devices and equipment. Orthrobiologics devices are implants composed of cells and proteins naturally found in human body that provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues including bones, cartilage, tendons and ligaments. They consist of tissues and bone replacement materials used for recovery of ligaments, tendons, muscles and bones. Orthobiologics devices and equipment include demineralized bone matrix, synthetic, synthetic bone substitute, bone marrow aspirate concentrate and viscosupplementation.

Regulatory changes are likely to lead to increased costs relating to new product development and supply of orthobiologics devices. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures and other regulatory changes. The GDPR regulation is a EU law on data protection and privacy of individuals residing the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. In November 2017, the USFDA has announced comprehensive regenerative medicine policy framework to facilitate innovation. This policy deals with the manufacture of tissues, human cells, and cellular and tissue-based products other procedures to prevent the introduction, transmission, and spread of communicable diseases. Orthobiologics such as stem cell therapies are approved through this framework. The potential loss of revenue due to delays in product release, additional costs incurred the time consuming approval processes and changing regulations puts strain to investments relating to orthobiologics devices development.

Biodegradable implants are increasingly being used in orthobiologics treatment and trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as reabosorbable polymers composed of polyglycolic acid and poly lactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures, can degrade at a rate matching new tissue formation, eliminate the need for second surgery, and highly useful in fracture fixation in children with less implant related infections. For instance, Stryker Corp. offers orthobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration and muscle connection to bone.

The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew from by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to increase the demand for orthobiologics devices and equipment market.

Rising incidences of post-surgical complications in patients implanted with orthobiologics devices is one the major restraints in the orthobiologics devices and equipment market. Surgical procedures with orthobiologics grafts, implants and devices have become increasingly common in recent years. Major post-operative complications include device failures, bleeding, postoperative infections, immune responses and rejections. These procedures may develop post-surgery complications which refer to development of any unwanted or unexpected conditions related to the device, graft, or implant. These complications may vary with the type of procedure, implant, graft or device, experience of the surgeon, improper device testing procedures before market launch, device location in the body and the health and biological response of the individual. The increasing post-operative complications and device failures can limit the orthobiologics devices and equipment market.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Medtronic
  • Arthrex Inc.
  • DePuy Synthes (A Subsidiary of Johnson & Johnson)
  • Stryker Corporation
  • Zimmer Biomet
  • Bioventus LLC
  • Baxter International Inc.
  • Integra Lifesciences Holding Corporation
  • Nuvasive INC.
  • Sanofi
  • Seaspine Holdings Corporation
  • Bone Biologics
  • Corp.
  • Pioneer Surgical Technology
  • Smith & Nephew plc
  • Osiris Therapeutics Inc.
  • Globus Medical
  • Wright Medical Technology
  • Orthofix Inc.
  • Harvest Technologies Corporation (A Terumo Bct Company)
  • Globus Medical Inc.
  • RTI Surgical Inc
  • K2M Group Holdings Inc.
  • Kuros Biosciences Ltd.
  • Xtant Medical Holdings Inc.
  • Biomet
Note: Product cover images may vary from those shown

Loading
LOADING...